Correlation Between Cullinan Oncology and IO Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and IO Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and IO Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and IO Biotech, you can compare the effects of market volatilities on Cullinan Oncology and IO Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of IO Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and IO Biotech.

Diversification Opportunities for Cullinan Oncology and IO Biotech

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Cullinan and IOBT is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and IO Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IO Biotech and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with IO Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IO Biotech has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and IO Biotech go up and down completely randomly.

Pair Corralation between Cullinan Oncology and IO Biotech

Given the investment horizon of 90 days Cullinan Oncology LLC is expected to generate 0.38 times more return on investment than IO Biotech. However, Cullinan Oncology LLC is 2.61 times less risky than IO Biotech. It trades about -0.15 of its potential returns per unit of risk. IO Biotech is currently generating about -0.07 per unit of risk. If you would invest  1,886  in Cullinan Oncology LLC on August 29, 2024 and sell it today you would lose (609.00) from holding Cullinan Oncology LLC or give up 32.29% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Cullinan Oncology LLC  vs.  IO Biotech

 Performance 
       Timeline  
Cullinan Oncology LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cullinan Oncology LLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
IO Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days IO Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Cullinan Oncology and IO Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cullinan Oncology and IO Biotech

The main advantage of trading using opposite Cullinan Oncology and IO Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, IO Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IO Biotech will offset losses from the drop in IO Biotech's long position.
The idea behind Cullinan Oncology LLC and IO Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Bonds Directory
Find actively traded corporate debentures issued by US companies
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world